Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: DanZ who wrote (1162)	10/21/1999 11:02:00 PM
From: Mike M	Respond to of 5582

Dan, you know I cannot get myself to argue w/ these guys. I think the world is full of people who will and wont use Zicam....I don't wear tank tops, but they seem to sell a lot of them.... What is going to convince someone who wont be convinced. There are 6 Billion people in the world. What if only .1 of 1% use Zicam. That figures to 60,000,000 people. I can live with that....You want a smaller number....well then we are going to have to negotiate.... Seriously, I have a feeling that the numbers who want speedy relief of a cold will stagger the imagination. Still others will want to be able to avoid the cold where possible. It is and always will be a marketing issue. I think the doubters are going to squawk until the numbers hit them where it hurts. I personally have purchased ten bottles of Zicam....I have given six of them away to people who had colds. Four of them were intrigued enough to go out and buy the medication to use again or give to others. Any number of us have similar stories. There are many aging people who have to worry about complications developing from colds. Hospitals, nurseries etc...all have great need to stem the cold. So a couple dog pounders don't see the need. People have been trying to get me to sell my PFE for thirty years. No stock is for everybody. That article in Woman's World Magazine is one of the first indications that the marketing team is starting to get the message out. IMO the momentum will build and the stock will rise long before these guys ever see confirming revenue. This stock is risky. There are plenty of investors who won't touch a stock until the revenues are in the billions. That is supposed to make them more predictable. So LLY drops 6 points the other day....IBM was off 16 at one point today..... Predictability isn't all it is cracked up to be.... I cannot imagine shorting this stock any more than these two guys can imagine owning it..... I can live with that. Regards, Mike

To: DanZ who wrote (1162)	10/22/1999 10:37:00 AM
From: Hank	Read Replies (1) \| Respond to of 5582

Zicam Trial- Day 4 Well, I really believed when I went to bed last night that I was on the verge of being 100% cold free. Unfortunately, the 15 minutes I spent this morning blowing my nose and hacking up phlegm from my lungs convinced me otherwise. I don't feel too bad. At least, not bad enough to not go on my hunting trip this weekend. However, I am definitely not 100%. Apparently, Zicam was incapable of completely eliminating this cold in 3 days, as many predicted. Did it help? I think so but I honestly can't say for sure. Assuming that it did help, was the effect significant enough for me to want to use it again? Probably not but then I'll reserve final judgement for when I really do reach that 100% mark. Actually, I should get a good idea this weekend as to how long this cold would have lasted had I not taken Zicam at all. I went to my hunting camp last weekend with two hunting buddies. One came down with a cold over the weekend. About two days after we broke camp, both myself and my other buddy came down with the same cold (I presume. Too coincidental otherwise). Both of those guys will be back at camp this weekend and I know for certain neither one has ever even heard of Zicam. It will be interesting to see how their colds progressed compared to mine. Hopefully, it will give me a better handle on whether or not Zicam has actually made a difference in my case. Kind of like a mini placebo controlled clinical study. At any rate, I will not be able to post any final conclusions on this matter until next week. Dan- if you wish to forward my comments to GUMM management, then be my guest. See you next week.